P3 Health Partners: Q4 Earnings Insights
Portfolio Pulse from Benzinga Insights
P3 Health Partners (NASDAQ:PIII) reported Q4 earnings with an EPS of $-0.22, missing estimates by -100.0% against an expected $-0.11. Revenue increased by $88.66 million from the same period last year. Despite missing this quarter's earnings estimate, the company had previously beaten EPS estimates in Q3 2023, which led to a 6.0% share price increase the following day.
March 28, 2024 | 9:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
P3 Health Partners reported a significant miss in Q4 earnings with an EPS of $-0.22, which was 100% below the estimated $-0.11. However, revenue showed a substantial increase from the previous year.
The significant miss in EPS estimates for Q4 is likely to negatively impact investor sentiment in the short term, especially considering the stock's positive reaction to the previous quarter's earnings beat. However, the substantial year-over-year revenue increase may provide some buffer against negative sentiment.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100